Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $75.99 and last traded at $75.23, with a volume of 10550 shares trading hands. The stock had previously closed at $74.89.
Novozymes A/S Trading Down 1.7%
The company has a quick ratio of 1.06, a current ratio of 1.73 and a debt-to-equity ratio of 0.14. The company has a market cap of $34.03 billion, a P/E ratio of 45.99 and a beta of 0.92. The business has a 50-day moving average price of $67.68 and a two-hundred day moving average price of $61.11.
About Novozymes A/S
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Further Reading
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
